Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical cash
Cash and short-term investments held at the end of each period.
Acro Biomedical's cash was $3.65K at Jun 30, 2026. For fiscal 2025 it was $4.10K, up 760.9% from the year before. Over ten years it grew 0.4% a year on average. The highest annual figure on record is $95.25K in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.10K | +760.9% |
| FY2024 | Dec 31, 2024 | $476 | +26.6% |
| FY2023 | Dec 31, 2023 | $376 | -93.6% |
| FY2022 | Dec 31, 2022 | $5.85K | -93.9% |
| FY2021 | Dec 31, 2021 | $95.25K | +6370.7% |
| FY2019 | Sep 30, 2019 | $1.47K | +28.2% |
| FY2018 | Sep 30, 2018 | $1.15K | -96.9% |
| FY2017 | Sep 30, 2017 | $36.81K | +1353.2% |
| FY2016 | Sep 30, 2016 | $2.53K | -90.7% |
| FY2015 | Sep 30, 2015 | $27.28K | +594.9% |
| FY2014 | Sep 30, 2014 | $3.93K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $3.65K | +13930.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $3.87K | +1443.0% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $4.10K | +760.9% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $4.32K | +516.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $26 | -97.2% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $251 | +66.2% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $476 | +26.6% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $701 | -78.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $926 | -65.4% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $151 | -53.1% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $376 | -93.6% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $3.27K | -79.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $2.68K | -77.9% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $322 | -99.9% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $5.85K | -93.9% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $16.19K | -89.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $12.11K | -94.4% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $357.67K | +1368.3% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $95.25K | +6370.7% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $154.66K | +66853.7% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $215.49K | +52204.4% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $24.36K | -35.2% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $1.47K | +28.2% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $231 | -95.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $412 | -99.9% |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $37.61K | +340.3% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $1.15K | -96.9% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $4.62K | +93.0% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | $471.83K | +18527.4% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $8.54K | +299.0% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $36.81K | +375.5% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $2.39K | -85.0% |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $2.53K | -90.7% |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | $2.14K | -92.6% |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $7.74K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | $15.91K | – |
| Q4 FY2015CQ3 2015 | Sep 30, 2015 | $27.28K | – |
| Q3 FY2015CQ2 2015 | Jun 30, 2015 | $28.79K | – |
See a number that looks wrong?